You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
佳兆業健康(00876.HK)年度扭虧為盈至188.5萬港元,義齒業務復甦而平穩上升
格隆匯 03-30 21:18

格隆匯3月30日丨佳兆業健康(00876.HK)發佈公吿,截至2021年12月31日止12個月,公司收益為2.10億港元,同比增長14.04%;公司擁有人應占溢利188.5萬港元,上年同期虧損3969.2萬港元;每股盈利0.04港仙。

年度銷售額因集團的義齒業務復甦而平穩上升。其他收益有所增加,主要因為出售按公平值計入損益之金融資產約1260萬港元所致。於2021年12月31日,來自義齒業務之收益約為2.01億港元,而於2020年同期的收益則約為1.80億港元。

集團主要從事義齒業務,其業務戰略為透過加大擴展業務,以進一步提升股東價值。打造"美加"品牌,以先進技術為導向,融合國內、外優質醫療器械資源,成為高端義齒耗材供應商。集團積極探索以口腔上下游為產業鏈的醫療器械體系,以醫養、康養結合的醫療服務體系,三大體系相互協同,形成生態閉環

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account